Safety and Immunogenicity of a Cell Derived Subunit Trivalent Nonadjuvated Influenza Study Vaccine in Adults Aged 18 Years and Above
Clinical trial NCT01640314 · COMPLETED
Trial details
- NCT number
- NCT01640314
- Sponsor
- Novartis Vaccines
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-01
- Primary completion
- 2012-08-01
- Enrollment
- 126
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.